‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

Vulcan Steel leads as reporting season approaches
Markets Market Close

Vulcan Steel leads as reporting season approaches

The S&P/NZX 50 Index closed 55.30 points higher at 12,889.38.

Jamie Gray 15 Aug 2025
Competition law changing to allow 'beneficial collaboration'
Markets

Competition law changing to allow 'beneficial collaboration'

Confidential submissions to the Commerce Commission will get a 10-year OIA exemption.

Pattrick Smellie 15 Aug 2025
Small cap spotlight: Blackpearl Group
Markets Small Cap Wrap

Small cap spotlight: Blackpearl Group

Founder Nick Lissette says it's patriotic to be listed, but hard work.

NZ sharemarket rises, Vista Group shares fall
Markets Market Close

NZ sharemarket rises, Vista Group shares fall

The New Zealand sharemarket was up on Thursday as most stocks on the main board lifted.

Tom Raynel 14 Aug 2025